 | |||
|
ECOG Introduction to ECOG Clinical Trials Guide For Cancer Patients What is a clinical trial? Why participate? Does insurance cover costs? What if I change my mind? How can I join a clinical trial? ECOG's active protocols Patient Information Selenium E5597 GI Studies E4203,E5202,E5204 Melanoma E2603 Prostate CHAARTED E3805 Cancer in Siblings E1Y97 Non-Hodgkins Lymphoma E4402 Breast Cancer PACCT1: TAILORx Informational Videos Trial Summary Results Trial Monitoring ECOG Data Monitoring Committee ECOG Institutions Institutions by state Alphabetical listing Joining ECOG Publications Publications bibliography Announcements TAILORx Webinar Information NCI Press Release: Bevacizumab... Job Openings Future ECOG Meeting Dates Researcher Advocate Partners Investigator Awards NCI-VA Initiative Scales and Criteria ECOG Performance Status Common Toxicity Criteria Cancer Information Breast Cancer Video Colon Cancer Video Cancer Survivor Publications Releasing Results Guidelines Other Cancer Sites ECOG Main Institutions' Sites Other Cooperative Groups Advocates/Support Groups 
ECOG MEMBERS
|
Eastern Cooperative Oncology Group:E5597 Phase III Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non Small Cell Lung Cancer You can learn more about this trial by viewing a short informational video featuring Dr. Joseph Aisner, the principal investigator for this trial:
Click here for a list of institutions participating in this trial Note to institutions: Use of these videos for patient education requires approval of your institution's IRB. This research is being done because it is unknown if taking selenium can prevent the development of second lung cancers. You can find additional information about lung cancer and its treatment at the following web sites: National Cancer Institute Lung Cancer Information CancerCare- It's Time To Focus On Lung Cancer Information about cancer clinical trials can be found at: |